Maternal Mental Health Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Indication (Postpartum Depression, Dysthymia, Pregnancy and Postpartum General Anxiety, Pregnancy and Postpartum OCD, Birth-Related PTSD, Others), By Therapy (Interpersonal Psychotherapy, Antidepressants, Cognitive Behavioral Therapy, others), By Region & Competition, 2020-2030F
Market Report I 2025-05-30 I 182 Pages I TechSci Research
Market Overview
The Global Maternal Mental Health Market was valued at USD 5.83 billion in 2024 and is projected to reach new growth levels by 2030, expanding at a CAGR of 9.23%. Maternal mental health, encompassing conditions such as postpartum depression, anxiety, and PTSD, is increasingly recognized as a public health priority. These mental health challenges can arise during pregnancy or the postpartum period and have serious implications for both mother and child, including premature birth and developmental issues. Rising awareness, the normalization of seeking help, and improved access to mental healthcare services are contributing to the market's growth. Additionally, healthcare providers and policy makers are implementing more comprehensive screening and treatment strategies. Technological advancements, including mobile health apps, wearable monitoring devices, and AI-powered analytics, are also playing a pivotal role in early detection and personalized intervention. The increasing global birth rate, coupled with heightened awareness and support infrastructure, is expected to fuel robust growth in the maternal mental health market over the coming years.
Key Market Drivers
High Prevalence of Maternal Mental Health Disorders is Driving Global Maternal Mental Health Market
The increasing recognition of the prevalence and impact of perinatal mental health disorders is a primary driver for the market. Conditions such as postpartum depression, general anxiety, and PTSD are now known to affect a substantial proportion of women during and after pregnancy. Studies indicate that up to one in seven women in the U.S. experience postpartum depression, with other regions reflecting similarly high rates. The COVID-19 pandemic further intensified maternal mental health concerns, with research from the University of Michigan highlighting that nearly one in three mothers during early 2020 experienced symptoms of depression. This growing awareness has encouraged greater demand for mental health services tailored specifically to the maternal population. Healthcare systems, non-profits, and governments are increasingly supporting maternal mental health programs, while tech firms and pharmaceutical companies are innovating around treatment and support tools, further driving market expansion.
Key Market Challenges
Stigma and Awareness
One of the major obstacles hindering market growth is the persistent stigma surrounding mental health during and after pregnancy. Many women feel pressured to conform to societal expectations that motherhood should be a purely joyful experience, leading to feelings of guilt or fear of judgment if they disclose emotional distress. As a result, many mothers delay or avoid seeking treatment altogether. Compounding this issue is the lack of consistent mental health screening in prenatal and postpartum care. To combat these barriers, efforts must focus on awareness campaigns, caregiver training, and integration of mental health checks into routine maternal care. Destigmatizing maternal mental health through education and supportive community platforms remains essential to unlocking further growth in the market.
Key Market Trends
Technological Advancements
Technology is playing a transformative role in the maternal mental health market. The rise of telehealth has made it easier for women to access care from the safety and privacy of their homes. Mobile apps designed for mood tracking, meditation, and personalized support are becoming more prevalent, offering scalable and accessible mental health solutions. Wearable technologies also support continuous monitoring of vital signs and stress indicators, enabling early detection of mental distress. Artificial Intelligence is being used to analyze behavioral and physiological data, helping predict mental health risks and guide timely interventions. Moreover, Virtual Reality is emerging as a therapeutic tool for treating postpartum anxiety and PTSD by offering immersive relaxation and exposure therapy experiences. Collectively, these technological developments are helping to reduce barriers to care, improve treatment personalization, and enhance patient engagement.
Key Market Players
- Therapy Mama
- Canopie
- Pfizer Inc
- Viatris Inc.
- GlaxoSmithKline Inc.
- Alembic Pharmaceuticals Limited
- Mallinckrodt Inc.
- Sage Therapeutics, Inc.
- Bausch Health Companies Inc.
- Magellan Health, Inc.
Report Scope:
In this report, the Global Maternal Mental Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Maternal Mental Health Market, By Disease Indication:
o Postpartum Depression
o Dysthymia
o Pregnancy and Postpartum General Anxiety
o Pregnancy and Postpartum OCD
o Birth-Related PTSD
o Others
- Maternal Mental Health Market, By Therapy:
o Interpersonal Psychotherapy
o Antidepressants
o Cognitive Behavioral Therapy
o Others
- Maternal Mental Health Market, By Region:
o North America
United States
Canada
Mexico
o Europe
France
United Kingdom
Italy
Germany
Spain
o Asia-Pacific
China
India
Japan
Australia
South Korea
o South America
Brazil
Argentina
Colombia
o Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Maternal Mental Health Market.
Available Customizations:
Global Maternal Mental Health market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
4. Voice of Customer
5. Global Maternal Mental Health Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Disease Indication (Postpartum Depression, Dysthymia, Pregnancy and Postpartum General Anxiety, Pregnancy and Postpartum OCD, Birth-Related PTSD, Others)
5.2.2. By Therapy (Interpersonal Psychotherapy, Antidepressants, Cognitive Behavioral Therapy, others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Maternal Mental Health Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Disease Indication
6.2.2. By Therapy
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Maternal Mental Health Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Disease Indication
6.3.1.2.2. By Therapy
6.3.2. Canada Maternal Mental Health Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Disease Indication
6.3.2.2.2. By Therapy
6.3.3. Mexico Maternal Mental Health Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Disease Indication
6.3.3.2.2. By Therapy
7. Europe Maternal Mental Health Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Disease Indication
7.2.2. By Therapy
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Maternal Mental Health Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Disease Indication
7.3.1.2.2. By Therapy
7.3.2. United Kingdom Maternal Mental Health Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Disease Indication
7.3.2.2.2. By Therapy
7.3.3. Italy Maternal Mental Health Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecasty
7.3.3.2.1. By Disease Indication
7.3.3.2.2. By Therapy
7.3.4. France Maternal Mental Health Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Disease Indication
7.3.4.2.2. By Therapy
7.3.5. Spain Maternal Mental Health Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Disease Indication
7.3.5.2.2. By Therapy
8. Asia-Pacific Maternal Mental Health Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Disease Indication
8.2.2. By Therapy
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Maternal Mental Health Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Disease Indication
8.3.1.2.2. By Therapy
8.3.2. India Maternal Mental Health Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Disease Indication
8.3.2.2.2. By Therapy
8.3.3. Japan Maternal Mental Health Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Disease Indication
8.3.3.2.2. By Therapy
8.3.4. South Korea Maternal Mental Health Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Disease Indication
8.3.4.2.2. By Therapy
8.3.5. Australia Maternal Mental Health Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Disease Indication
8.3.5.2.2. By Therapy
9. South America Maternal Mental Health Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Disease Indication
9.2.2. By Therapy
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Maternal Mental Health Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Disease Indication
9.3.1.2.2. By Therapy
9.3.2. Argentina Maternal Mental Health Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Disease Indication
9.3.2.2.2. By Therapy
9.3.3. Colombia Maternal Mental Health Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Disease Indication
9.3.3.2.2. By Therapy
10. Middle East and Africa Maternal Mental Health Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Disease Indication
10.2.2. By Therapy
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Maternal Mental Health Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Disease Indication
10.3.1.2.2. By Therapy
10.3.2. Saudi Arabia Maternal Mental Health Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Disease Indication
10.3.2.2.2. By Therapy
10.3.3. UAE Maternal Mental Health Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Disease Indication
10.3.3.2.2. By Therapy
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition
12.2. Product Development
12.3. Recent Developments
13. Global Maternal Mental Health Market: SWOT Analysis
14. Competitive Landscape
14.1. Therapy Mama
14.1.1. Business Overview
14.1.2. Application Offerings
14.1.3. Recent Developments
14.1.4. Key Personnel
14.1.5. SWOT Analysis
14.2. Canopie
14.3. Pfizer Inc
14.4. Viatris Inc.
14.5. GlaxoSmithKline Inc.
14.6. Alembic Pharmaceuticals Limited
14.7. Mallinckrodt Inc.
14.8. Sage Therapeutics, Inc.
14.9. Bausch Health Companies Inc.
14.10. Magellan Health, Inc.
15. Strategic Recommendations
16. About Us & Disclaimer
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.